Transform your delicate ADC molecule into a stable quality product with our expert CRO formulation services!
ProJect Pharmaceutics is a CRO specialized in formulation and lyophilization process development for antibody-drug conjugates. We have been developing ADCs in our dedicated safety laboratories for > 15 years and have seen all generations of ADCs on our workbench. By combining protein formulation and process know-how with cytotoxic drug expertise the company holds unique assets to develop ADC drug products. By means of modern and advanced screening technologies we accelerate formulation development and target a formulation that suits antibody, linker and payload to stabilize the ADC at its “sweet spot”.
